SCHEMBL14037970

SCHEMBL14037970

C=C(Nc1cc(C)c(C)c(-c2ccc(OC)nc2)n1)C1(c2ccc3c(c2)OC(F)(F)O3)CC1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 12/20 0.46
▸ NR1I2 O75469 1/20 0.46
▸ ADORA3 P0DMS8 1/20 0.46
▸ CYP2C8 P10632 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ ADRA1A P35348 1/20 0.46
▸ PDE4D Q08499 1/20 0.46
▸ POLQ O75417 1/20 0.35
▸ GPR183 P32249 1/20 0.34
▸ KIT P10721 2/20 0.34
▸ PDE2A O00408 1/20 0.33
▸ STIM1 Q13586 1/20 0.33
▸ ORAI1 Q96D31 1/20 0.33
▸ CYP2A6 P11509 1/20 0.32
▸ GPR55 Q9Y2T6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3672957 0.90 CFTR (0.57) CFTRNR1I2ADORA3CYP2C8CYP2C9
SCHEMBL16168276 0.86 CFTR (0.44) CFTRNR1I2ADORA3CYP2C8CYP2C9
SCHEMBL3671482 0.81 CFTR (0.67) CFTRNR1I2ADORA3CYP2C8CYP2C9
SCHEMBL3809245 0.80 CFTR (0.54) CFTRNR1I2ADORA3CYP2C8CYP2C9
SCHEMBL3670411 0.80 CFTR (0.55) CFTRNR1I2ADORA3CYP2C8CYP2C9
SCHEMBL16161109 0.79 CFTR (0.57) CFTRNR1I2ADORA3CYP2C8CYP2C9
SCHEMBL14038104 0.79 CFTR (0.47) CFTRNR1I2ADORA3CYP2C8CYP2C9
SCHEMBL3672585 0.79 CFTR (0.58) CFTRNR1I2ADORA3CYP2C8CYP2C9
SCHEMBL16541446 0.79 CFTR (0.50) CFTR
SCHEMBL4053349 0.77 CFTR (0.53) CFTRNR1I2ADORA3CYP2C8CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789606-B1 Modulators of CFTR VERTEX PHARMA (US) 2017-11-15 — — EP disclosed
WO-2008141119-A2 MODULATORS OF CFTR VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-11-20 — — WO disclosed
Send feedback